Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (6)
  • 2025 (30)
  • 2024 (32)
  • 2023 (35)
  • 2022 (26)
  • 2021 (52)
  • 2020 (50)
  • 2019 (54)
  • 2018 (50)
  • 2017 (45)
  • 2016 (29)
  • 2015 (28)
  • 2014 (23)
  • 2013 (47)
  • 2012 (15)
  • 2011 (47)
  • 2005 (6)

Subject

  • Drug Trafficking (50)
  • Take Back Day (38)
  • Outreach/Drug Prevention (34)
  • Fake Pills (33)
  • Prescription Drugs (29)
  • Fentanyl Awareness (22)
  • One Pill Can Kill (19)
  • Public and Media Affairs - also see Congressional Affairs (18)
  • Synthetic drugs (18)
  • Arrests/Convictions - Major (17)
  • Diversion Division (15)
  • Major Law Enforcement Operation (15)
  • Press Conferences (15)
  • Congressional Affairs (12)
  • Guns/Weapons (12)
  • Pharmaceuticals/Pharmacists/Physicians (12)
  • Seizures (Drugs/Property) (12)
  • Prevention/Education - DEA websites GSAD, JTT etc (9)
  • Red Ribbon (9)
  • Money Laundering (8)
  • OCDETF/Task Force (6)
  • Gangs (5)
  • Overdose (5)
  • Counterfeit Pills (4)
  • Extraditions (4)
  • Fentanyl Free America (4)
  • Intergovernmental Affairs (4)
  • International/Foreign Operations (4)
  • Narcoterrorism (4)
  • Critical Incident (3)
  • HIDTA (3)
  • Campaigns (2)
  • Guilty Plea (2)
  • Intelligence Division - Intelligence Products (2)
  • Scam Calls (2)
  • Task Forces/Task Force Officers (2)
  • Terrorism (2)
  • Asset Forfeiture (1)
  • Dark Web- Internet Trafficking (1)
  • Museum and Visitors Center (1)
  • Other (1)

Drug Name

  • Fentanyl (76)
  • Methamphetamine (46)
  • Cocaine (35)
  • Heroin (23)
  • Marijuana (Cannabis) (15)
  • Oxycodone (9)
  • Synthetic Opioids (8)
  • Opioids (6)
  • Marijuana Concentrates (2)
  • Benzodiazepines (1)
  • Ecstasy/MDMA (1)
  • GHB (1)
  • Ketamine (1)
  • Psilocybin (1)

Field Division

  • New England (2385)
  • New York (1521)
  • Houston (907)
  • San Francisco (847)
  • Miami (840)
  • Seattle (812)
  • St. Louis (808)
  • Atlanta (777)
  • Chicago (629)
  • Washington, DC (617)
  • New Jersey (493)
  • New Orleans (481)
  • Detroit (361)
  • El Paso (350)
  • Dallas (315)
  • Los Angeles (300)
  • Phoenix (274)
  • San Diego (246)
  • Philadelphia (140)
  • Omaha (137)
  • Louisville (81)
  • Caribe (79)
  • Caribe (1)
  • Sede (414)
  • Rocky Mountain (166)
Clear All Results
575 Results - Showing 401 to 410
PRESS RELEASE

DEA’s National Prescription Drug Take-Back Day Is Saturday

WASHINGTON - After collecting and destroying 5.5 million pounds-2,762 tons-of unused prescription drugs in the past five years, the U.S. Drug Enforcement (DEA) is continuing its efforts to take back unused, unwanted and expired prescription medications. The DEA invites the public to bring their potentially dangerous, unwanted medicines to one...
PRESS RELEASE

Former Parker Doctor, Office Manager, And Two Pharmacists Indicted For Conspiracy And Illegal Distribution Of Prescription Medication Resulting In Patient Deaths

DENVER - Dr. John Alan Littleford, and three others were indicted by a federal grand jury in Denver last week on charges related to the illegal distribution of prescription medication and money laundering, DEA Special Agent in Charge Barbra Roach, U.S. Attorney John Walsh and IRS Criminal Investigation Special Agent...
PRESS RELEASE

DEA And FBI Team Up To Fight Opioid And Prescription Drug Abuse Sweeping Colorado And The Country

Premier Colorado screening of Chasing the Dragon: Life of an Opiate Addict, with panel discussion DENVER - An opioid and prescription drug abuse epidemic is sweeping Colorado and the rest of the nation, impacting all segments of society. To help raise awareness and educate young people about the dangers of...
PRESS RELEASE

Maltz Challenge At Training Center Of Super Bowl Champion Denver Broncos

DENVER - The DEA Denver Field Division held the annual Maltz Challenge at the new Denver Broncos Dove Valley practice facility. The intense physical challenge was held to honor the nation’s fallen heroes. The Division was joined by a large contingent of community and employee volunteers including Assistant Special Agent...
PRESS RELEASE

DEA Meets With Pharmaceutical Industry Leaders Today To Discuss Collaboratively Preventing Prescription Drug Misuse And Abuse

WASHINGTON - U.S. Drug Enforcement (DEA) Acting Administrator Chuck Rosenberg and the Chief of DEA’s Office of Diversion Control, Lou Milione hosted a meeting today in Washington with industry leaders representing the prescription drug supply chain in America. The purpose of their dialogue was to discuss ways to minimize pharmaceutical...
PRESS RELEASE

DEA Administrator Chuck Rosenberg Statement On Walgreens’ Prescription Drug Take Back Initiative

WASHINGTON - The United States Drug Enforcement (DEA) commends Walgreens for their commitment to install secure collection bins for unused prescription drugs in over 500 of their stores in 40 states. "Take back programs are an important and easy way for the public to anonymously dispose of their unwanted, unused...
PRESS RELEASE

FBI, DEA Release Documentary Film Addressing Heroin/Prescription Drug Abuse

WASHINGTON - In an effort to combat the growing epidemic of prescription drug and heroin abuse, leaders of the FBI and DEA today unveiled a documentary aimed at educating students and young adults about the dangers of the addiction. “Chasing the Dragon” is a 45-minute documentary film that profiles the...
PRESS RELEASE

DEA And European Authorities Uncover Massive Hizballah Drug And Money Laundering Scheme

WASHINGTON - The United States Drug Enforcement (DEA) today announced significant enforcement activity including arrests targeting Lebanese Hizballah’s External Security Organization Business Affairs (BAC), which is involved in international criminal activities such as drug trafficking and drug proceed money laundering. These proceeds are used to purchase weapons for Hizballah for...
PRESS RELEASE

DEA Statement On The Capture Of Joaquin “Chapo” Guzman-Loera

WASHINGTON - The capture of Joaquin “Chapo” Guzman-Loera is a victory for the rule of law and the Mexican people and government. The arrest is a significant achievement in our shared fight against transnational organized crime, violence, and drug trafficking. It is further evidence of our two countries’ resolve to...
PRESS RELEASE

DEA Eases Requirements For FDA-Approved Clinical Trials On Cannabidiol

WASHINGTON - The United States Drug Enforcement (DEA) recently eased some of the regulatory requirements imposed by the Controlled Substances (CSA) for those who are conducting FDA-approved clinical trials on (CBD), an extract of the marijuana plant. These modifications will streamline the research process regarding CBD’s possible medicinal value and...

Paginación

  • Primera página «
  • Anterior
  • Page 37
  • Page 38
  • Page 39
  • Page 40
  • Current page 41
  • Page 42
  • Page 43
  • Page 44
  • Page 45
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster